Herpes zoster vaccination in the elderly subjects: improving awareness and uptake

References

• Paek E, Johnson R. Public awareness and knowledge of herpes zoster: results of a global survey. Gerontology. 2010;56:20–31.
   Web of Science ®Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1–30.
   PubMedGoogle Scholar
• Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365–1376.
   PubMed Web of Science ®Google Scholar
• Weaver BA. Herpes zoster overview: natural history and incidence. J Am Osteopath Assoc. 2009;109(S2):S2–S6.
   Google Scholar
• Okamoto S, Hata A, Sadaoka K, Yamanishi K, Mori Y. Comparison of varicella-zoster virus specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis. 2009;200:1606–1610.
   PubMed Web of Science ®Google Scholar
• Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010;9:21–26.
   PubMed Web of Science ®Google Scholar
• Thyregod HG, Rowbotham MC, Peters M, Possehn J, Berro M, Petersen KL. Natural history of pain following herpes zoster. Pain. 2007;128:148–156.
   PubMed Web of Science ®Google Scholar
• Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26–33.
   PubMed Web of Science ®Google Scholar
• Lee VK, Simpkins L: Herpes zoster and postherpetic neuralgia in the elderly. Geriatr Nurs. 2000;21:132–136.
   Web of Science ®Google Scholar
• Gross G, Schöfer H, Wassilew S, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol. 2003;26(3):277–289.
   Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–1349.
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Volpi A, McKendrick M, Wijck Av, Oaklander AL. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol. 2010;48(Suppl 1):S20–S28.
   PubMedGoogle Scholar
• Johnson RW, McElhaney J, Pedalino B, Levin M. Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis. 2007;11(Suppl 2):S43–S48.
   Google Scholar
• Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86(2):88–93.
   PubMed Web of Science ®Google Scholar
• Drolet M, Oxman MN, Levin MJ, et.al. Vaccination against herpes zoster in developed countries. Hum Vaccin Immunother. 2013;9(5):1177–1184.
   PubMed Web of Science ®Google Scholar
• Jeon YH. Herpes Zoster and Postherpetic Neuralgia: practical consideration for prevention and treatment. Korean J Pain. 2015;28(3):177–184.
   PubMedGoogle Scholar
• Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012;29:863–869.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81(10):928–930.
   PubMed Web of Science ®Google Scholar
• Janninger CK, Eastern JS, Hospenthal DR, Moon JE. Herpes zoster. Emedicine. 2013; Medscape reference number 1132465.
   Google Scholar
• Gnann JW Jr, Whitley RJ. Clinical practice: herpes zoster. N Engl J Med. 2002;347:340–346.
   PubMed Web of Science ®Google Scholar
• Meister W, Neiss A, Gross G, et al. Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology. 1998;41:272–277.
   PubMed Web of Science ®Google Scholar
• Haanpää M, Laippala P, Nurmikko T. Pain and somatosensory dysfunction in acute herpes zoster. Clin J Pain. 1999;15:78–84.
   PubMed Web of Science ®Google Scholar
• Ropper AH, Samuels MA. Viral infections of the nervous system, chronic meningitis, and prion diseases. In: Adams and Victor’s Principles of Neurology. 9th ed. New York: McGraw-Hill, Inc.; 2009:711–745.
   Google Scholar
• Opstelten W, Zaal MJ. Managing ophthalmic herpes zoster in primary care. BMJ. 2005;331:147–151.
   PubMed Web of Science ®Google Scholar
• Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40(11):3443–3448.
   Web of Science ®Google Scholar
• Wagner G, Klinge H, Sachse MM. Ramsay Hunt syndrome. J Dtsch Dermatol Ges. 2012;10(4):238–244.
   Web of Science ®Google Scholar
• WHO. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946, and entered into force on April 7, 1948.
   Google Scholar
• Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Z Gesundh Wiss. 2012;20:441–451.
   PubMedGoogle Scholar
• WHO. Varicella and herpes zoster vaccines: WHO position paper, Jun 2014. Wkly Epidemiol Rec. 2014;89(25):265–287.
   PubMedGoogle Scholar
• CDC. Shingles (Herpes Zoster): Diagnosis and Testing; May 2014. Available from: http://www.cdc.gov/shingles/hcp/diagnosis-testing.html.
   Google Scholar
• Galluzzi KE. Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc. 2007;107(Suppl 1):S8–S13.
   Google Scholar
• Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Phys. 2011;83(12):1432–1437.
   Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113–1123.
   PubMed Web of Science ®Google Scholar
• Oxman MN. Immunization to reduce the frequency and severity of Herpes Zoster and its complications. Neurology. 1995;45(12 Suppl 8):S41–S46.
   PubMed Web of Science ®Google Scholar
• Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis. 1998;178(Suppl 1):S109–S112.
   PubMed Web of Science ®Google Scholar
• Trannoy E, Berger R, Holländer G, et al. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine. 2000;18:1700–1706.
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, et al. A Vaccine to prevent Herpes Zoster and Postherpetic Neuralgia in older adult. N Engl J Med. 2005;352:2271–84.
   PubMed Web of Science ®Google Scholar
• Schmader KE, Levin MJ, Gnann JW Jr, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in person aged 50-59 years. Clin Infect Dis. 2012;54(7):922–928.
   PubMed Web of Science ®Google Scholar
• Breuer J. Vaccination to prevent varicella and shingles. J Clin Pathol. 2001;54:743–747.
   PubMed Web of Science ®Google Scholar
• Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003;188:1336–1344.
   PubMed Web of Science ®Google Scholar
• Schmader KE, Oxman MN, Levin MJ, et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis. 2012;55:1320–1328.
   PubMed Web of Science ®Google Scholar
• Morrison VA, Johnson GR, Schmader KE, et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis. 2015;60(6):900–909.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305:160–166.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xie F, Delzell E, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA. 2012;308(1):43–49.
   PubMed Web of Science ®Google Scholar
• Gagliardi AMZ, Gomez Liva BN, Torloni MR, Soares BGO. Vaccines for preventing herpes zoster in older adults [review]. Cochrane Database Syst Rev. 2012;10:CD008858.
   Google Scholar
• Diez-Domingo J, Weinke T, Garcia de Lomas J, et al. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged >50 years: a randomised non-inferiority clinical trial. Vaccine. 2015;33(6):789–795.
   Web of Science ®Google Scholar
• European Medicines Agency. Zostavax (shingles [herpes zoster] vaccine [live]): EU summary of product characteristics; 2015. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/%20EPAR_-_Summary_for_the_public/human/000674/WC500053457.pdf.
   Google Scholar
• Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009;27(6):882–887.
   Google Scholar
• National Center for Health Statistics (NCHS). Health, United States; 2005. Available from: http://www.cdc.gov/nchs/data/hus/hus05.pdf#088.
   Google Scholar
• Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin Infect Dis. 2007;44:1532–1535.
   PubMed Web of Science ®Google Scholar
• Public Health England. Herpes zoster (shingles) immunisation programme 2013/14: cumulative coverage data (provisional) for England to end-April 2014. Health Protection Report. 8(21), May 30, 2014.
   Google Scholar
• Ministere des affaires sociales, de la santé et des droit des femmes. Arrêté du 5 juin 2015 modifiant la liste des spécialités pharmaceutiques remboursables aux assurés sociaux. Journal Officiel de la Republique Francaise. 2015 n. 132 Available from: http://www.legifrance.gouv.fr/eli/arrete/2015/6/5/AFSS1512658A/jo/texte.
   Google Scholar
• Van Epps P, Schmader KE, Canaday DH. Herpes zoster vaccination: controversies and common clinical questions. Gerontology. Epub July 16, 2015.
   Google Scholar
• Williams WW, Lu PJ, O’Halloran A, et al; Centers for Disease Control and Prevention (CDC). Vaccination coverage among adults, excluding influenza vaccination – United Sates, 2013. MMWR. 2015;64(4):95–102.
   PubMed Web of Science ®Google Scholar
• Teeter BS, Garza KB, Stevenson TL, Williamson MA, Zeek ML, Westrick SC. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies. Vaccine. 2014;32:5749–5754.
   Web of Science ®Google Scholar